Feed Category: Psychedlics Index

Incannex HealthcareMELBOURNE, Australia and NEW YORK, Nov. 29, 2023 (GLOBE NEWSWIRE) — Incannex Healthcare Inc. (NASDAQ: IXHL) is pleased to announce that its previously announced… [Read More]

Expands intellectual property portfolio with composition of matter and methods of use claims governing Enveric’s EVM301 Series of drug candidatesCAMBRIDGE, Mass., November 29, 2023–(BUSINESS WIRE)–Enveric… [Read More]

TORONTO, ON / ACCESSWIRE / November 28, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (“FSD Pharma” or the “Company”), is a biopharmaceutical company dedicated to building… [Read More]

Peer-reviewed article describes the creation of a library of novel prodrug derivatives of psilocin from which EB-373 was selectedCAMBRIDGE, Mass., November 27, 2023–(BUSINESS WIRE)–Enveric Biosciences… [Read More]

TORONTO, ON / ACCESSWIRE / November 27, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (“FSD Pharma” or the “Company”), a biopharmaceutical company dedicated to building a… [Read More]

CAMBRIDGE, Mass., November 24, 2023–(BUSINESS WIRE)–Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics… [Read More]

BALTIMORE, MD / ACCESSWIRE / November 24, 2023 / Goldman Small Cap Research, a stock market research firm specializing in the small cap and microcap… [Read More]

Shares of Intra-Cellular Therapies (ITCI) have gained 22.4% over the past four weeks to close the last trading session at $59.26, but there could still… [Read More]

TORONTO, ON / ACCESSWIRE / November 21, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (“FSD Pharma” or the “Company”), a biopharmaceutical company dedicated to building a… [Read More]

– Company speakers include Doug Drysdale, Chief Executive Officer; and Amir Inamdar, MBBS, DNB (Psych), MFPM, Chief Medical Officer — Featured key opinion leaders include… [Read More]

TORONTO, ON / ACCESSWIRE / November 17, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (“FSD Pharma” or the “Company”), a biopharmaceutical company dedicated to building a… [Read More]

Incannex HealthcareMELBOURNE, Australia, Nov. 16, 2023 (GLOBE NEWSWIRE) — Incannex Healthcare Limited (ASX: IHL) (NASDAQ: IXHL) (the “Company” or “Incannex”) is pleased to announce that… [Read More]